<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract Objective </plain></SENT>
<SENT sid="1" pm="."><plain>Early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), defined here as <z:hpo ids='HP_0011007'>age of onset</z:hpo> less than 40 years, develops frequently in genetically predisposed individuals </plain></SENT>
<SENT sid="2" pm="."><plain>Next-generation sequencing is an increasingly available option in the diagnostic workup of suspected hereditary susceptibility, but little is known about the practical feasibility and additional diagnostic yield of the technology in this patient group </plain></SENT>
<SENT sid="3" pm="."><plain>Materials and methods </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed 38 young <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients derived from a set of 1514 CRC cases </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 38 tumors had been tested in our laboratory for microsatellite instability (MSI), and Sanger sequencing had been used to screen for MLH1 and MSH2 mutations in MSI cases </plain></SENT>
<SENT sid="6" pm="."><plain>Also, gastrointestinal <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> had been diagnosed clinically and molecularly </plain></SENT>
<SENT sid="7" pm="."><plain>Family histories were acquired from national registries </plain></SENT>
<SENT sid="8" pm="."><plain>If inherited syndromes had not been diagnosed in routine diagnostic efforts (n = 23), <z:mpath ids='MPATH_458'>normal</z:mpath> tissue DNA was analyzed for mutations in a comprehensive set of high-penetrance genes (MLH1, MSH2, MSH6, PMS2, APC, MUTYH, SMAD4, BMPR1A, LKB1/STK11, and PTEN) by exome sequencing </plain></SENT>
<SENT sid="9" pm="."><plain>Results </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> predisposition syndromes were confirmed in 42% (16/38) of early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">Hereditary nonpolyposis colorectal cancer</z:e> was diagnosed in 12 (32%) patients, <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> in three (7.9%), and <z:e sem="disease" ids="C0345893" disease_type="Neoplastic Process" abbrv="JPS|JIP|PJI">juvenile polyposis</z:e> in one (2.6%) patient </plain></SENT>
<SENT sid="12" pm="."><plain>Exome sequencing revealed one additional MLH1 mutation </plain></SENT>
<SENT sid="13" pm="."><plain>Over half of the patients had <z:e sem="disease" ids="C0877373" disease_type="Neoplastic Process" abbrv="">advanced cancers</z:e> (Dukes C or D, 61%, 23/38) </plain></SENT>
<SENT sid="14" pm="."><plain>The majority of nonsyndromic patients had unaffected first-degree relatives and microsatellite-stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="16" pm="."><plain>Microsatellite instability positivity or gastrointestinal <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> characterized <z:hpo ids='HP_0000001'>all</z:hpo> patients with unambiguous highly penetrant germline mutations </plain></SENT>
<SENT sid="17" pm="."><plain>In our series, exome sequencing produced little added value in diagnosing the underlying predisposition conditions </plain></SENT>
</text></document>